Yanyang
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- $15M
Investors
- 5
About Yanyang
, trading as Yanyang, is a drug developer that focuses on the development of therapeutic biological products (live microecological bacteria) and microecological products in the field of health. In 2019, the company established the toxicology evaluation of vaginal bacteria. In 2020, it established a bacterial medicine intelligent manufacturing platform and an anaerobic live bacteria pilot test platform. It was honoured the Science and Technology-based Small and Medium-sized Enterprises, and National High-tech Enterprises. Yanyang has technologies such as high-throughput screening of anaerobic microorganisms, evaluation of high-efficiency bacteria drugs, and storage and transportation of live bacteria. It also created a resource bank of human anaerobic microorganisms. Yanyang's pipeline of products can be categorized into three types which are human bacterial reservoirs, reproductive tract bacteriophages, and intestinal bacteria. Products within include vaginal bacteria and intestinal bacteria. Intestinal bacteria drugs are used in chemotherapy-related diarrhea, tumors, metabolic diseases, autoimmunity and other fields. The products can be used in the treatment of diseases in relevant parts of the human body.
Who invested in Yanyang
5 investors across 2 rounds
See all investors in Yanyang
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Yanyang
Who invested in Yanyang?
Yanyang has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Yanyang raised?
Yanyang has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Yanyang last raise money?
Yanyang's most recent round on record is a Series A, in Jan 2026.
What does Yanyang do?
, trading as Yanyang, is a drug developer that focuses on the development of therapeutic biological products (live microecological bacteria) and microecological products in the field of health.
Where is Yanyang headquartered?
Yanyang is headquartered in Chengdu, China.
Which VCs invest in companies like Yanyang?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Yanyang's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Yanyang? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.